Optimal Passive Dilation Time in Retrograde Intrarenal Surgery

Sponsor
Ankara Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05340088
Collaborator
(none)
50
1
5
9.9

Study Details

Study Description

Brief Summary

Retrograde intrarenal surgery (RIRC) is used as standard treatment for stones less than 2 cm. In some cases, the ureteral access sheath cannot be placed due to ureteral stricture. In this case, a double j stent (DJ) is placed to passively dilate the ureter, and the RIRC is postponed for post-dilatation. The aim of the study is to determine the optimal time for RIRC operation in cases where a double j stent was placed for passive dilatation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Retrograde intrarenal surgery after DJ stent placement

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Case-Only
Time Perspective:
Retrospective
Official Title:
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Actual Study Start Date :
Sep 1, 2021
Actual Primary Completion Date :
Jan 1, 2022
Actual Study Completion Date :
Feb 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Patients who underwent RIRC for 2-4 weeks after DJ stent placement for passive dilatation

Patients who underwent RIRC for 2-4 weeks after DJ stent placement for passive dilatation

Procedure: Retrograde intrarenal surgery after DJ stent placement
Patients who underwent RIRC for 2-4 weeks after DJ stent placement for passive dilatation

Patients who underwent RIRC for 4-6 weeks after DJ stent placement for passive dilatation

Patients who underwent RIRC for 4-6 weeks after DJ stent placement for passive dilatation

Procedure: Retrograde intrarenal surgery after DJ stent placement
Patients who underwent RIRC for 2-4 weeks after DJ stent placement for passive dilatation

Outcome Measures

Primary Outcome Measures

  1. BMI in kg/m^2 [3 Months]

    BMI in kg/m^2the kidney, operation time(minute)

  2. serum creatinine mg/dl [3 Months]

    serum creatinine mg/dl

Secondary Outcome Measures

  1. mm size of the stone [3 Months]

    mm size of the stone

  2. localization of the stone in the kidney, [3 Months]

    localization of the stone in the kidney,

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with a DJ stent for passive dilatation and subsequent RIRC
Exclusion Criteria:
  • Urinary tract infection, patients with ureteral compression and a history of pelvic radiotherapy, urinary system tumor

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara Training and Research Hospital Ankara Altindag Turkey 06230

Sponsors and Collaborators

  • Ankara Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ali Kaan Yildiz, Principal Investigator, Ankara Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05340088
Other Study ID Numbers:
  • DJRIRS2022
First Posted:
Apr 21, 2022
Last Update Posted:
Apr 21, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 21, 2022